Raimundo F. Bezares

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants.

Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants.

Journal: Annals of hematology

Published: January 22, 2024

Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia.

Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia.

Journal: Frontiers in oncology

Published: January 13, 2023

Bruton tyrosine kinase inhibitors. What does the oncohematologist and the cardiologist need to know?

Bruton tyrosine kinase inhibitors. What does the oncohematologist and the cardiologist need to know?

Journal: Medicina

Published: December 26, 2022

HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America.

HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America.

Journal: JCO global oncology

Published: March 04, 2022

Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients.

Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients.

Journal: Annals of hematology

Published: March 05, 2021

Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype.

Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype.

Journal: Cancer immunology, immunotherapy : CII

Published: February 08, 2021

Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia.

Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia.

Journal: Haematologica

Published: October 15, 2020

In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia.

In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia.

Journal: Frontiers in oncology

Published: August 24, 2020

The effect of ibrutinib on neutrophil and γδ T cell functions.

The effect of ibrutinib on neutrophil and γδ T cell functions.

Journal: Leukemia & lymphoma

Published: April 21, 2020

Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.

Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.

Journal: Cancer immunology, immunotherapy : CII

Published: July 16, 2019

Distinctive IGHV gene usage and stereotyped receptors in South American patients with chronic lymphocytic leukemia.

Distinctive IGHV gene usage and stereotyped receptors in South American patients with chronic lymphocytic leukemia.

Journal: Hematological oncology

Published: June 05, 2019

Analysis of basal chromosome instability in patients with chronic lymphocytic leukaemia.

Analysis of basal chromosome instability in patients with chronic lymphocytic leukaemia.

Journal: Mutagenesis

Published: October 25, 2018

Showing 1-12 of 29

Last Updated: 09/26/2026